TOC
Home > People at the DRFZ > Prof. Dr. Chiara Romagnani

Prof. Dr. Chiara Romagnani

Programme Area 1, PA 1 – Cell and Tissue Rheumatology

Group leader: Innate Immunity

Liaison working group with Charité - Institute of Medical Immunology

+49 (0)30 28460-681

romagnani@drfz.de

Scientific Background

Since 2023
Full Professor (W3) and Director, Institute of Medical Immunology, Charité – Universitätsmedizin Berlin, Germany

2020 – 2023
Full Professor (W3), Charité Universitätsmedizin Berlin and Chair, Leibniz Campus “Chronic Inflammation”, DRFZ, Berlin, Germany

2017 – 2020
Heisenberg Professor (W2), Department for Gastroenterology, Infectious Diseases, Rheumatology, Charité, Berlin, Germany

Since 2010
Group leader, DRFZ, Berlin, Germany

2006 – 2009
Postdoc, Institute of Immunology, Charité and DRFZ, Berlin, Germany

2003 – 2006
PhD

1997 – 1998
MD

Since 2024
Elected member Deutsche Forschungsgemeinschaft (DFG)– Fachkollegium „Mikrobiologie, Virologie, Immunologie“

Since 2023
ERC Starting Grant Panel member

Since 2022
Chief Editor, European Journal of Immunology

Since 2021
Deputy Speaker, Else Kröner-Promotionskolleg “Rethinking Health”

Since 2020
Speaker, PhD program “Interdisciplinary Center of Infection Biology and Immunity” (ZIBI), Berlin

Since 2020
Editorial Advisory Board, Immunity (Cell Press)

2020-2024
Speaker of the Leibniz Science Campus “Chronic Inflammation”

Since 2019
Committee member, Robert-Koch Postdoctoral Prize

Since 2018
Speaker, Integrated Research and Training Group of CRC TRR241

Since 2018
Board elected member, German Society of Immunology (DGfI)

German Society of Immunology (DGfI)

2024
Elected member of the Deutsche Akademie der Naturforscher Leopoldina

2023
Berlin University Alliance (BUA) Joint Professorship Charité Universitätsmedizin and Freie Universität Berlin

2022
ERC Advanced Grant

2017
DFG-Heisenberg Professorship

2016
DFG-nominated member of AcademiaNet – “Expert Database for Outstanding Female Academics”

2006
EMBO fellowship

TOP 5 PUBLICATIONS

*equal contribution, # open access
Clonal expansion and epigenetic inheritance of long-lasting NK cell memory Rückert T, Lareau CA, Mashreghi MF, Ludwig LS, and Romagnani C. Clonal expansion and epigenetic inheritance of long-lasting NK cell memory. Nat Immunol. 2022 Nov;23(11):1551-1563. doi: 10.1038/s41590-022-01327-7. PMID: 36289449. #
T-bet and RORα control lymph node formation by regulating embryonic innate lymphoid cell differentiation Stehle C, Rückert T, Fiancette R, Gajdasik DW, Willis C, Ulbricht C, Durek P, Mashreghi MF, Finke D, Hauser AE, Withers DR, Chang HD, Zimmermann J*, and Romagnani C*. 2021. T-bet and RORα control lymph node formation by regulating embryonic innate lymphoid cell differentiation. Nat Immunol. 2021 Oct;22(10):1231-1244. doi: 10.1038/s41590-021-01029-6. PMID: 34556887 #
An in vitro platform supports generation of human innate lymphoid cells from CD34+ hematopoietic progenitors that recapitulate ex vivo identity Hernández DC, Juelke K, Müller NC, Durek P, Ugursu B, Mashreghi MF, Rückert T, and Romagnani C. 2021. An in vitro platform supports generation of human innate lymphoid cells from CD34+ hematopoietic progenitors that recapitulate ex vivo identity. Immunity. Oct 12;54(10):2417-2432.e5. doi: 10.1016/j.immuni.2021.07.019. PMID: 34453879. #
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells Hammer Q, Rückert T, Borst EM, Dunst J, Haubner A, Durek P, Heinrich F, Gasparoni G, Babic M, Tomic A, Pietra G, Nienen M, Blau IW, Hofmann J, Na IK, Prinz I, Koenecke C, Hemmati P, Babel N, Arnold R, Walter J, Thurley K, Mashreghi MF, Messerle M, and Romagnani C. 2018. Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells. Nat Immunol. May;19(5):453-463. doi: 10.1038/s41590-018-0082-6. PMID: 29632329.
Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells Montaldo E, Teixeira-Alves LG, Glatzer T, Durek P, Stervbo U, Hamann W, Babic M, Paclik D, Stölzel K, Gröne J, Lozza L, Juelke K, Matzmohr N, Loiacono F, Petronelli F, Huntington ND, Moretta L, Mingari MC, and Romagnani C. 2014. Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells. Immunity. Dec 18;41(6):988-1000. doi: 10.1016/j.immuni.2014.11.010. PMID: 25500367. #

Innate Immunity

Romagnani lab
learn more

News

Go to end of slider
  • News

Pettenkofer Prize for Timo Rückert

Dr. Timo Rückert, postdoc in Chiara Romagnani’s liaison research group at DRFZ and the Institute of Medical Immunology at Charité – Universitätsmedizin Berlin, has been…
Show more

Projects

Go to end of slider
Show more